Law360 (July 28, 2020, 5:09 PM EDT) -- A drug delivery patch-maker on Tuesday said it had agreed to buy CBD manufacturer Sera Labs, one of several companies sued by Clint Eastwood last week for allegedly advertising with a bogus endorsement from the Hollywood legend, in a deal worth $20 million.
Cure Pharmaceutical's deal with Sera Labs, which has denied authorizing the fake Eastwood advertorial, includes $1 million in cash and $19 million in Cure stock, along with a potential $20 million earn-out for Sera if the company meets certain performance targets.
In connection with the agreement, Cure is also loaning Sera $500,000 in exchange for a note locking...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!